lactic acid and saquinavir

lactic acid has been researched along with saquinavir in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Kuo, YC; Yu, HW1
Ball, C; Chaowanachan, T; Krogstad, E; Woodrow, KA1
Banerjee, S; Jain, NK; Kesharwani, P; Mehra, NK; Singh, R; Singh, S1
Gan, Y; He, Y; Li, Q; Shen, A; Tao, J; Wang, C; Xia, D1

Other Studies

5 other study(ies) available for lactic acid and saquinavir

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Expression of ornithine decarboxylase during the transport of saquinavir across the blood-brain barrier using composite polymeric nanocarriers under an electromagnetic field.
    Colloids and surfaces. B, Biointerfaces, 2011, Dec-01, Volume: 88, Issue:2

    Topics: Blood-Brain Barrier; Cell Line; Cell Survival; Electromagnetic Fields; Humans; Lactic Acid; Nanoparticles; Nanotechnology; Ornithine Decarboxylase; Polyethyleneimine; Polyglutamic Acid; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Saquinavir

2011
Drug synergy of tenofovir and nanoparticle-based antiretrovirals for HIV prophylaxis.
    PloS one, 2013, Volume: 8, Issue:4

    Topics: Adenine; Alkynes; Animals; Anti-HIV Agents; Benzoxazines; Cell Line; Cervix Uteri; Chemistry, Pharmaceutical; Cyclopropanes; Delayed-Action Preparations; Drug Carriers; Drug Synergism; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Inhibitory Concentration 50; Lactic Acid; Macaca; Models, Biological; Nanoparticles; Organophosphonates; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Saquinavir; Spectroscopy, Fourier Transform Infrared; Tenofovir; Tissue Culture Techniques

2013
Development and characterization of folate anchored Saquinavir entrapped PLGA nanoparticles for anti-tumor activity.
    Drug development and industrial pharmacy, 2015, Volume: 41, Issue:11

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Drug Carriers; Drug Compounding; Drug Delivery Systems; Endocytosis; Female; Folic Acid; Humans; Lactic Acid; Male; MCF-7 Cells; Nanoparticles; Particle Size; Polyesters; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prostatic Neoplasms; Saquinavir

2015
Self-Assembled Core-Shell-Type Lipid-Polymer Hybrid Nanoparticles: Intracellular Trafficking and Relevance for Oral Absorption.
    Journal of pharmaceutical sciences, 2017, Volume: 106, Issue:10

    Topics: Animals; Biological Transport; Caco-2 Cells; Cell Line, Tumor; Clathrin; Drug Carriers; Drug Delivery Systems; Endocytosis; Exocytosis; Humans; Intestinal Mucosa; Lactic Acid; Lipids; Nanoparticles; Particle Size; Phospholipids; Pinocytosis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rats; Saquinavir; Transcytosis

2017